GV 2017 GP, L.L.C. — SEC Form 4 filings

SEC reporting owner CIK 1733338. 2 Form 4 filings on record with FilingPulse; latest filed 2026-01-30.

Transaction summary — filings shown

Covers all 2 filings on record, filed 2025-07-28 to 2026-01-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Ethos Technologies Inc. (LIFE)10% owner12 legs · 1,845,308 sh · $35,060,8526
Verve Therapeutics, Inc. (VERV)10% owner13

Form 4 filings — GV 2017 GP, L.L.C.

FiledFormIssuerReported transactionsSource
2026-01-304Ethos Technologies Inc. (LIFE)
jointly with GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2021 GP, L.L.C., GV 2021 GP, L.P., GV 2021, L.P., Alphabet Inc.
Conversion (C): 1,755,632 · Conversion (C): 3,287,925 · Conversion (C): 571,907 · Sale (S): 1,755,632 @ $19 · Sale (S): 89,676 @ $19 · Conversion (C): 1,751,791 (derivative) · +2 moreEDGAR
2025-07-284Verve Therapeutics, Inc. (VERV)
jointly with GV 2017 GP, L.P., GV 2017, L.P., GV 2019 GP, L.L.C., GV 2019 GP, L.P., GV 2019, L.P., GV 2023 GP, L.L.C., GV 2023 GP, L.P., GV 2023, L.P., Alphabet Inc.
Code (U): 6,108,442 · Code (U): 4,260,047 · Code (U): 1,800,000EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1733338 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →